Human immunodeficiency virus therapies utilizing N332-glycan-dependent antibodies and a reservoir activator

• 收藏
• 分享

专利权人:

Beth Israel Deaconess Medical Center; Inc.

发明人:

Dan H. Barouch

申请号：

US15025961

公开号：

US10376583B2

申请日:

2014.09.30

申请国别(地区):

US

年份:

2019

代理人:

摘要：

This invention relates to antibody therapies for human immunodeficiency virus (HIV). In particular, the invention provides methods of curing subjects infected with HIV and blocking HIV infections in subjects at risk of HIV transmission using a N332 glycan-dependent antibody (e.g., PGT121).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/